Johnson Matthey Escapes Shire's Vyvanse Patent Suit
A New Jersey federal judge Thursday released Johnson Matthey Inc. from Shire LLC's suit accusing it of infringing patents on attention deficit hyperactivity disorder drug Vyvanse, nearly four months after the...To view the full article, register now.
Already a subscriber? Click here to view full article